title: Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.
abstract: We have used E1A probes to study the roles of the p34cdc2 kinase and the retinoblastoma tumor susceptibility gene product (pRB) in transforming growth factor beta 1 (TGF beta 1)-mediated growth suppression in mink lung epithelial (Mv1Lu) cells. In agreement with previous reports, we see a decline in p34cdc2 kinase activity and a loss of pRB phosphorylation after TGF beta 1 treatment. We report here that TGF beta 1 induces not only a change in p34cdc2 kinase activity but a strong repression of p34cdc2 synthesis. Loss of p34cdc2 kinase activity is not seen until the steady-state level of p34cdc2 declines, suggesting that the intra-cellular signals induced by TGF beta 1 affect p34cdc2 at the level of expression, rather than by altering the posttranslational modifications of p34cdc2 that regulate its kinase activity. Infection with adenovirus expressing either wild-type E1A or a mutant E1A (pm928) defective for pRB binding alleviated TGF beta 1-mediated suppression of DNA synthesis, indicating that E1A does not need to bind pRB physically to keep cell growth-suppressing functions from being activated by TGF beta 1. The E1A.928 mutant virus is able to maintain p34cdc2 expression and kinase activity, as well as pRB phosphorylation in the presence of TGF beta 1, which may account for its ability to maintain cell cycle activity without directly sequestering pRB. Overall our results suggest that TGF beta 1 acts by signaling changes at the level of control of G1 gene expression, not at the level of posttranslational modification of p34cdc2 or its substrates.
authors.affiliation: Cold Spring Harbor Laboratory, New York 11724.
authors.forename: S E
authors.initials: SE
authors.lastname: Abraham
authors.forename: M C
authors.initials: MC
authors.lastname: Carter
authors.forename: E
authors.initials: E
authors.lastname: Moran
mesh_terms: D000256:Adenoviridae / Q000502:physiology*; D017456:Adenovirus Early Proteins; D000818:Animals; D016203:CDC2 Protein Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D002455:Cell Division / Q000502:physiology; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D007700:Kinetics; D008907:Mink; D009856:Oncogene Proteins, Viral / Q000378:metabolism; D010766:Phosphorylation; D006656:Protamine Kinase / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000502:physiology*
chemical_list: D017456:Adenovirus Early Proteins; D009856:Oncogene Proteins, Viral; D016160:Retinoblastoma Protein; D016212:Transforming Growth Factor beta; D004247:DNA; D006656:Protamine Kinase; D016203:CDC2 Protein Kinase